NPS Pharmaceuticals to Present at the JPMorgan 26th Annual Healthcare Conference on January 9, 2008



    BEDMINSTER, N.J., Dec. 21 /CNW/ -- NPS Pharmaceuticals, Inc. (Nasdaq:  
NPSP) announced today that Dr. Anthony Coles, president and CEO, will present
a company update at the JPMorgan 26th Annual Healthcare Conference in San
Francisco, CA at 8:30 a.m. PST on Wednesday, January 9, 2008. The live event
webcast may be accessed on the NPS site, http://www.npsp.com. A replay will be
available approximately 24 hours after the presentation has concluded and may
be accessed at the same link.

    About NPS Pharmaceuticals

    NPS Pharmaceuticals is a biopharmaceutical company focused on the
development and commercialization of small molecules and recombinant proteins
as drugs, primarily for the treatment of metabolic, bone and mineral, and
central nervous system disorders. The company has drug candidates in various
stages of clinical development. Additional information is available on the
company's website, http://www.npsp.com.




For further information:

For further information: Brandi Simpson of NPS Pharmaceuticals, Inc., 
+1-908-450-5616, Web Site: http://www.npsp.com

Organization Profile

NPS PHARMACEUTICALS, INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890